Search clinical trials for: Apatinib, VEGFR2 antibody
Total 5101 results
-
Sichuan Cancer Hospital and Research InstituteNot yet recruitingIntrahepatic Cholangiocarcinoma | Apatinib | PD-1 Antibody | Transarterial ChemoembolizationChina
-
Bristol-Myers SquibbCompletedLeukemia, Myeloid, Chronic-Phase (CML-CP)
-
Washington University School of MedicineWithdrawn
-
National Research Center for Hematology, RussiaActive, not recruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia in Remission | BCR-ABL Positive Chronic Myelogenous LeukemiaRussian Federation
-
Norwegian University of Science and TechnologyCompletedChronic Myeloid LeukemiaSweden, Finland, Norway
-
Tracon Pharmaceuticals Inc.TerminatedRenal Cell CarcinomaUnited States, Hungary, Czechia, United Kingdom
-
M.D. Anderson Cancer CenterCERN Foundation - Collaborative Ependymoma Research NetworkCompletedBrain Cancer | Pediatric CancersUnited States
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; Guangdong Provincial...Active, not recruitingColorectal Cancer | Microsatellite Instability HighChina
-
Shenzhen People's HospitalUnknownNSCLC | Apatinib | EGFR-TKIChina
-
Bristol-Myers SquibbPPD; ICON Clinical Research; Q2 Solutions; Molecular MD; MultiPharma; Steering Committee and other collaboratorsCompletedChronic Phase Chronic Myeloid LeukemiaItaly, Thailand, United States, Belgium, Czechia, Hungary, Argentina, Austria, Brazil, Canada, China, France, Korea, Republic of, Poland, Spain
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Spain, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Puerto Rico, Singapore, South Africa, Taiwan, United Kingdom, Australia, France, Philippines, Sweden, Thailand, Russian Federation, China, Poland, Finland, Isra... and more
-
Newcastle UniversityBristol-Myers Squibb; Institute of Cancer Research, United Kingdom; Newcastle-upon-Tyne... and other collaboratorsCompletedMyeloid Leukemia, Chronic, Chronic PhaseUnited Kingdom
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, ChronicGermany, India, Japan, Korea, Republic of, Turkey, Chile, China, Spain, Australia, France, Poland, Mexico, Colombia, Belgium, Austria, Italy, Peru, Greece, Brazil, Czech Republic, Hungary, Russian Federation, Netherlands, Argentina, Den... and more
-
Beijing Dongfang Biotech Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesNot yet recruiting
-
Northwestern UniversityCompletedNeurofibromatosis Type 1 | Neurofibromatosis Type 2 | Adult Ependymoma | Recurrent Adult Brain Tumor | Acoustic Schwannoma | Adult Anaplastic Meningioma | Adult Grade I Meningioma | Adult Grade II Meningioma | Adult Meningeal Hemangiopericytoma | Adult Papillary MeningiomaUnited States
-
PfizerCompleted
-
Bristol-Myers SquibbCompletedLeukemiaGermany, Italy, Korea, Republic of, Sweden, Thailand, United States, Australia, France, Poland, Switzerland, Spain, Ireland, Peru, Brazil, South Africa, Canada, Argentina, Hungary, Finland, Israel, Norway, Russian Federation, United... and more
-
Sinocelltech Ltd.UnknownHead and Neck Squamous Cell CarcinomaChina
-
Huabo Biopharm Co., Ltd.Recruiting
-
Elevar TherapeuticsCompletedAdenoid Cystic CarcinomaUnited States, Korea, Republic of
-
Shanghai Jiao Tong University Affiliated Sixth...UnknownSoft Tissue Sarcoma
-
UNC Lineberger Comprehensive Cancer CenterCompletedChronic Myeloid Leukemia | Chronic Myeloid Leukemia, Chronic Phase | CML, Chronic Phase | CML - Philadelphia Chromosome | CML (Chronic Myelogenous LeukemiaUnited States
-
Oslo University HospitalThe Research Council of NorwayCompleted
-
Groupe Hospitalier Pitie-SalpetriereCompletedVascular Diseases | Cardiac ComplicationFrance
-
Shanghai Henlius BiotechNot yet recruiting
-
Shanghai Henlius BiotechRecruitingCutaneous Squamous Cell CarcinomaChina
-
Peking University Cancer Hospital & InstituteRecruiting
-
Tianjin Medical University Cancer Institute and...Unknown
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); NovoCure Ltd.CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
Wuhan Union Hospital, ChinaWithdrawnColorectal Cancer | Chemotherapy | Angiogenesis
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.Unknown
-
Masaryk UniversityActive, not recruitingChronic Myeloid Leukemia, Chronic Phase | Withdrawal;DrugCzechia
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.UnknownEsophageal CancerChina
-
Peking University Third HospitalUnknownNonsmall Cell Lung CancerChina
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingEsophageal Cancer by AJCC V8 StageChina
-
Peking UniversityJiangsu HengRui Medicine Co., Ltd.Recruiting
-
The First Affiliated Hospital of Zhengzhou UniversityRecruiting
-
Peking Union Medical College HospitalCompletedApatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer (ACABC)Cholangiocarcinoma | Hepatobiliary Neoplasm | Biliary Tract Cancer | BiomarkerChina
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 InhibitorChina
-
Peking Union Medical College HospitalCompleted
-
Huazhong University of Science and TechnologyUnknown
-
Dragonboat Biopharmaceutical Company LimitedUnknown
-
Jiangsu T-Mab Biopharma Co.,LtdUnknownNeovascular Age-Related Macular DegenerationChina
-
National Cancer Institute (NCI)TerminatedRenal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
Ruijin HospitalActive, not recruitingGastric and Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
Shoucheng MaUnknownColorectal NeoplasmsChina
-
Beijing HospitalChinese Society of Clinical OncologyRecruiting
-
Samsung Medical CenterAstraZenecaUnknownEGFR Mutation Positive Non-small Cell Lung CancerKorea, Republic of
-
Shanghai Jiao Tong University School of MedicineCompletedOral Cancer | VEGFR2 Inhibitor | Programmed Cell Death 1 Inhibitor | Inductive TherapyChina